Acquisition of abcam by danaher approved by the high court of justice of england and wales

Cambridge, england & waltham, mass.--(business wire)--abcam plc (nasdaq: abcm) (‘abcam', the ‘group' or the ‘company'), a global leader in the supply of life science research tools, entered into a definitive agreement on august 26, 2023 relating to its proposed acquisition by danaher corporation (nyse: dhr) (‘danaher') for $24.00 per share in cash (the ‘transaction'), to be implemented by way of a court-sanctioned scheme of arrangement under part 26 of the companies act 2006 (the ‘scheme‘). the.
ABCM Ratings Summary
ABCM Quant Ranking